Home › Funds › Patient Square Capital LP › FTH
Patient Square Capital LP position in FTH
FAETH THERAPEUTICS INC
Patient Square Capital LP reported holding 175,050 shares of FTH (FAETH THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.4M, representing 0.68% of its reported portfolio and ranking #23 among its reported holdings. Patient Square Capital LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Patient Square Capital LP's FTH position evolved
Patient Square Capital LP first disclosed a stake in FTH in Q2 2026 at 175,050 shares (US$4.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 175.05K | $4.38M | New |
About FTH and 13F data
FTH (FAETH THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 46 other funds we track also report a position in FTH — the largest reported positions include MONTANOVA CAPITAL, LLC (US$50.5M), Avoro Capital Advisors LLC (US$36.1M), BAKER BROS. ADVISORS LP (US$32.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding FTH
- MONTANOVA CAPITAL, LLC 2.02M sh · $50.50M · Q2 2026
- Avoro Capital Advisors LLC 1.44M sh · $36.10M · Q2 2026
- BAKER BROS. ADVISORS LP 1.29M sh · $32.16M · Q2 2026
- Fairmount Funds Management LLC 722.02K sh · $18.05M · Q2 2026
- Logos Global Management LP 722.02K sh · $18.05M · Q2 2026
- Vivo Capital, LLC 722.02K sh · $18.05M · Q2 2026
- Caligan Partners LP 629.47K sh · $15.74M · Q2 2026
- B Group, Inc. 610.17K sh · $15.25M · Q2 2026
- Trails Edge Capital Partners, LP 515.34K sh · $12.88M · Q2 2026
- Octagon Capital Advisors LP 361.01K sh · $9.03M · Q2 2026
- Cormorant Asset Management, LP 1.03M sh · $7.66M · Q2 2026
- Boxer Capital Management, LLC 180.50K sh · $4.51M · Q2 2026
More on Patient Square Capital LP
FAQ
How long has Patient Square Capital LP held FTH?
Patient Square Capital LP has disclosed FTH holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Patient Square Capital LP's current position in FTH?
As of Q2 2026, Patient Square Capital LP holds 175.05K shares of FTH (FAETH THERAPEUTICS INC), valued at $4.38M, representing 0.68% of its reported portfolio and ranking #23.
Has Patient Square Capital LP been buying or selling FTH?
In the latest 13F filing (Q2 2026), Patient Square Capital LP newly opened its position in FTH.
Which other funds hold FTH?
Other major institutional holders of FTH include MONTANOVA CAPITAL, LLC, Avoro Capital Advisors LLC, BAKER BROS. ADVISORS LP, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.